Aili Lu
Impact in
Papers in ⓘ
- Oncology 8
- Cancer Cells and Metastasis 3
- Pancreatic and Hepatic Oncology Research 3
- Viral-associated cancers and disorders 2
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Lixin Wang (6 shared papers)Fang Yuan (6 shared papers)Zhaohui Ma (4 shared papers)Rui-Hong Wang (3 shared papers)Jianwen Guo (1 shared paper)Yefeng Cai (1 shared paper)Yan Huang (1 shared paper)Huiping Li (3 shared papers)
- Journals
- Medicine (2 papers)Neuroreport (2 papers)Journal of Cancer (2 papers)International Journal of Medical Sciences (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Aili Lu
22 papers receiving 346 citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Microbiology 5
- Developmental Neuroscience 18
- Oncology 112
- Neurology 49
- Epidemiology 87
Countries citing papers authored by Aili Lu
This map shows the geographic impact of Aili Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aili Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aili Lu more than expected).
Fields of papers citing papers by Aili Lu
This network shows the impact of papers produced by Aili Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aili Lu. The network helps show where Aili Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Aili Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage Hit paper breakdown → | 2023 | 176 |
| 2 | 2015 | 27 | |
| 3 | 2008 | 17 | |
| 4 | 2023 | 17 | |
| 5 | 2018 | 16 | |
| 6 | 2022 | 15 | |
| 7 | 2004 | 11 | |
| 8 | 2020 | 10 | |
| 9 | 2010 | 9 | |
| 10 | 2020 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2017 | 6 | |
| 13 | Notch signaling mitigates chemotherapy toxicity by accelerating hematopoietic stem cells proliferation via c-Myc. | 2020 | 6 |
| 14 | 2021 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2021 | 2 |
About Aili Lu
Aili Lu is a scholar working on Oncology, Infectious Diseases, Molecular Biology, Neurology and Surgery, having authored 23 papers that have together received 351 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Viral-associated cancers and disorders (2 papers), Epigenetics and DNA Methylation (2 papers), Intensive Care Unit Cognitive Disorders (2 papers) and Epilepsy research and treatment (2 papers). The work is most often cited by research in Microbiology (5 citations), Developmental Neuroscience (18 citations), Oncology (112 citations), Neurology (49 citations) and Epidemiology (87 citations). Aili Lu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Lixin Wang, Fang Yuan, Zhaohui Ma, Rui-Hong Wang, Jianwen Guo, Yefeng Cai, Yan Huang, Huiping Li, Zeping Jiang and Songming Ding. Their work appears in journals such as Medicine, Neuroreport, Journal of Cancer, International Journal of Medical Sciences and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.